edgarshade
Bluelighter
(Reuters)
By Ben Hirschler
LONDON | Tue May 29, 2012 12:03am BST
http://uk.reuters.com/article/2012/05/28/us-cannabis-multiplesclerosis-idUKBRE84R0R020120528
By Ben Hirschler
LONDON | Tue May 29, 2012 12:03am BST
Cannabis capsules failed to slow the progression of multiple sclerosis in a large British study, dealing a blow to hopes that the drug could provide long-term benefits for patients with the debilitating nerve disease.
Despite promising signs in earlier, shorter studies, researchers found patients who took capsules containing tetrahydrocannabinol (THC), a key active ingredient in cannabis, fared no better than those given a placebo.
http://uk.reuters.com/article/2012/05/28/us-cannabis-multiplesclerosis-idUKBRE84R0R020120528
